These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17644216)

  • 1. Solubility of sparingly-soluble ionizable drugs.
    Avdeef A
    Adv Drug Deliv Rev; 2007 Jul; 59(7):568-90. PubMed ID: 17644216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities.
    Glomme A; März J; Dressman JB
    J Pharm Sci; 2005 Jan; 94(1):1-16. PubMed ID: 15761925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical aspects of partition measurements according to GLP rules].
    Takácsné Novák K
    Acta Pharm Hung; 1997 Sep; 67(5):179-91. PubMed ID: 9432865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility-excipient classification gradient maps.
    Avdeef A; Bendels S; Tsinman O; Tsinman K; Kansy M
    Pharm Res; 2007 Mar; 24(3):530-45. PubMed ID: 17245653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods.
    Avdeef A; Berger CM; Brownell C
    Pharm Res; 2000 Jan; 17(1):85-9. PubMed ID: 10714613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-metric solubility. 3. Dissolution titration template method for solubility determination.
    Avdeef A; Berger CM
    Eur J Pharm Sci; 2001 Dec; 14(4):281-91. PubMed ID: 11684402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of excipient based solubility increases using the CheqSol method.
    Etherson K; Halbert G; Elliott M
    Int J Pharm; 2014 Apr; 465(1-2):202-9. PubMed ID: 24513529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution--a validation study.
    Box KJ; Völgyi G; Baka E; Stuart M; Takács-Novák K; Comer JE
    J Pharm Sci; 2006 Jun; 95(6):1298-307. PubMed ID: 16552741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility-pH profiles of some acidic, basic and amphoteric drugs.
    Shoghi E; Fuguet E; Bosch E; Ràfols C
    Eur J Pharm Sci; 2013 Jan; 48(1-2):291-300. PubMed ID: 23178441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiometric CheqSol and standardized shake-flask solubility methods are complimentary tools in physicochemical profiling.
    Lucero-Borja D; Subirats X; Barbas R; Prohens R; Avdeef A; Ràfols C
    Eur J Pharm Sci; 2020 May; 148():105305. PubMed ID: 32184154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis.
    Avdeef A; Kansy M; Bendels S; Tsinman K
    Eur J Pharm Sci; 2008 Jan; 33(1):29-41. PubMed ID: 17983735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling, solubility and pK(a) of five sparingly soluble drugs.
    Domańska U; Pobudkowska A; Pelczarska A; Zukowski L
    Int J Pharm; 2011 Jan; 403(1-2):115-22. PubMed ID: 21034801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
    McNamara DP; Whitney KM; Goss SL
    Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt disproportionation: A material science perspective.
    Thakral NK; Kelly RC
    Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility.
    Tran PH; Tran TT; Lee KH; Kim DJ; Lee BJ
    Expert Opin Drug Deliv; 2010 May; 7(5):647-61. PubMed ID: 20205605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potentiometric titration method for the crystallization of drug-like organic molecules.
    Du-Cuny L; Huwyler J; Fischer H; Kansy M
    Int J Pharm; 2007 Sep; 342(1-2):161-7. PubMed ID: 17587517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral lipid-based formulations.
    Hauss DJ
    Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical comparison of shake-flask, potentiometric and chromatographic methods for lipophilicity evaluation (log P
    Port A; Bordas M; Enrech R; Pascual R; Rosés M; Ràfols C; Subirats X; Bosch E
    Eur J Pharm Sci; 2018 Sep; 122():331-340. PubMed ID: 30006180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionizable drugs and pH oscillators: buffering effects.
    Misra GP; Siegel RA
    J Pharm Sci; 2002 Sep; 91(9):2003-15. PubMed ID: 12210047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.